Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
T1 bladder cancer constitutes approximately 25% of incident bladder cancers, and as such carries an important public health impact. Notably, it has a heterogeneous natural history, with large variation in reported oncologic outcomes. Optimal risk-stratification is essential to individualize patient...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
IOS Press
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927848/ |